Free press releases distribution network?

Agency / Source: MedMarket Diligence, LLC

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Worldwide Market for Drug-Eluting Bare and Other Coronary Stents New Report MedMarket Diligence - Coronary artery disease is addressed by a range alternative treatment methodologies; percutaneous intervention with or without stenting, coronary artery bypass grafting alternatives and other options, but stents represent the fastest growing option
Worldwide Market for Drug-Eluting Bare and Other Coronary Stents New Report MedMarket Diligence

 

PRZOOM - /newswire/ - Foothill Ranch, CA, United States, 2009/04/08 - Coronary artery disease is addressed by a range alternative treatment methodologies; percutaneous intervention with or without stenting, coronary artery bypass grafting alternatives and other options, but stents represent the fastest growing option.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Consulting/Market Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

MedMarket Diligence, drawing on its coverage of coronary stents through the previously published MedMarkets publication and leveraging its expertise in assessing advanced medical technologies markets, is publishing its 2009 report, "Worldwide Market for Drug-Eluting, Bare, Bioresorbable and Other Coronary Stents, 2008-2017."

"The coronary stents market is extremely dynamic by virtue of the relative nascency of the market, particularly for drug-eluting stents (DES; first introduced in 2003). Rapidly growing to a $5 billion market initially dominated by leader Johnson & Johnson's CYPHER, then Boston Scientific's TAXUS, drug-eluting stents arguably represent a successful challenge to coronary artery bypass grafting in the treatment of coronary artery disease" says Patrick Driscoll, President of MedMarket Diligence.

The successes of J&J and Boston Scientific have spurred a stream of newcomers with DES products and other stent types to the market. A range of new stents, with different constructions, material types (including bioabsorbable), coating types and other variations are now at various stages of introduction to the market.

MedMarket Diligence's report #C245, "Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017," details the worldwide market for the use of coronary stents in the treatment of coronary artery disease. The report assesses the treatment of coronary artery disease by alternative treatment methodologies (percutaneous intervention with or without stenting, coronary artery bypass grafting alternatives and other medical/surgical treatment options), with estimated current/forecast caseload across treatment types. The report details currently approved coronary stents, providing data on current and forecast impact on the market. The report also details the current state of product development in bare stents, drug-coated or drug-eluting stents and bioabsorbable stents in coronary applications and details the products under development, the anticipated timeline and impact of their market introduction. The report assesses the current and ten-year forecast global market for coronary stents, with segmentation by U.S., Europe, Asia/Pacific and Rest of World. The report provides competitor market shares by these geographic regions. The leading and key emerging coronary stent manufacturers are profiled with current product offerings, development status and market strengths/advantages.

The report is being released in April 2009 and is available online, where it may be advance ordered (with discount) at the online store or via order form.

MedMarket Diligence (mediligence.com) provides data and insight to the medical products, investment and other industries on advanced medical technologies through focused medical technology market and assessment Reports and the Medtech Startups Database.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Consulting/Market Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: MedMarket Diligence, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Consulting/Market Research articles,
CATCH Visitors via Your Competitors Announcements!


Worldwide Market for Drug-Eluting Bare and Other Coronary Stents New Report MedMarket Diligence

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Patrick Driscoll 
949-859-3401 reports[.]mediligence.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any MedMarket Diligence, LLC securities in any jurisdiction including any other companies listed or named in this release.

Consulting/Market Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From MedMarket Diligence, LLC / Company Profile


Read Consulting/Market Research Most Recent Related Press Releases:

CulturePro Consulting and Inloso, LLC Announce Joint Venture
Kantar Unveils A New Corporate Identity Across its Operating Brands - Announces Launch of Two New Operating Brands
Kantar Unveils A New Corporate Identity - Launches Two New Operating Brands
Kantar and ComScore Expand Behavioural Data Partnership to North America
Frost & Sullivan Partners with Vaahika Under the ‘Companies to Action’ Program
Kantar's TNS Takes Full Ownership of TNS ICAP in Greece
TNS Takes Full Ownership of TNS ICAP in Greece
California Energy Commission Selects Energetics to Develop Research Roadmap
GroupM Launches LIVE Panel Connecting with Multiple Data Sources Across Kantar
Asia Transformationand Turnaround Association Partner with Institute for Turnaround

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com

Visit  NAKIVO, Inc.







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today